EMA: EMA releases guidance on the use of pharmacogenomics to improve safety monitoring of medicines

06.02.2014

The European Medicines Agency has released a draft guideline for public consultation which addresses how pharmacogenomics can support pharmacovigilance activities and in particular how the results of pharmacogenomic studies can help optimise the use of medicines.